Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07625436

Artificial Intelligence for Rare Disease Diagnosis

A multicentre, randomised diagnostic accuracy study to evaluate whether the rare disease-specific AI can improve diagnostic accuracy and efficiency for physicians managing real-world clinical cases.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Peking Union Medical College Hospital, Beijing, China

Loading trial locations.

About this study

Rare diseases collectively affect approximately 300 million individuals worldwide. This prolonged diagnostic delay is attributable in large part to the breadth of over 7,000 recognized rare conditions, which far exceeds the clinical exposure of any individual physician. A rare disease-specific diagnostic AI was developed by Peking Union Medical College Hospital (PUMCH), supporting differential diagnosis generation, clinical workup planning, and genomic variant interpretation. A balanced crossover design ensures that each enrolled physician serves as their own control, substantially reducing confounding from inter-reader variability in baseline diagnostic competency. Within each physician, cases are randomly assigned at the case level to either the AI-assisted or unassisted condition, such that each physician reads a subset of cases with AI assistance and the remaining cases without. This within-reader, case-level randomization eliminates the need for a washout period and directly controls for inter-reader differences in baseline diagnostic competency. All cases are collected from real-world clinical settings with independently confirmed gold-standard diagnoses and span a pre-specified spectrum of rare and non-rare disease categories, reflecting the differential diagnostic challenge encountered in routine clinical practice, to ensure diagnostic breadth and clinical representativeness. Physician seniority (junior vs. senior) is incorporated as a pre-specified stratification and subgroup analysis variable. Diagnostic outputs are evaluated by an independent Expert Adjudication Committee, blinded to the assistance condition, using standardized scoring criteria established prior to data collection.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1. Licensed physicians at the junior or senior level affiliated with internal medicine, neurology, pediatrics, and rare disease-related departments.
  • 2. Willingness to provide written informed consent, adhere to trial protocols, and complete all required pre-study training prior to enrollment.

Exclusion criteria

  • 1. Prior exposure to any of the clinical cases included in the study case library.
  • 2. Direct participation in the design or development of the AI model.

Treatment and study plan

AI-Assisted Diagnosis

Other

A rare disease-specific diagnostic AI model is used to accept free text input and assist in rare disease diagnoses. During the experimental condition, physicians may interact with the system freely alongside standard clinical resources to support their diagnostic reasoning.

Primary outcomes

  1. Top-3 Diagnostic Accuracy

    Time frame: Up to 60 minutes per case (from case presentation to diagnostic report submission).

    The percentage of definitive diagnosis is included within the physician's top 3 choices.

Secondary outcomes

  1. Diagnosis Time per Case

    Time frame: Up to 60 minutes per case (from case presentation to diagnostic report submission).

    Elapsed time from initial case presentation to final diagnostic report submission, recorded automatically via system logs.

  2. Workup Plan Quality

    Time frame: Up to 60 minutes per case (from case presentation to diagnostic report submission).

    Quality score of the clinical workup plan assigned by an independent expert committee using a standardized Likert Scale. Scores range from 1 to 10, with higher scores indicating better workup plan quality.

  3. Physician Reported Usability of the AI-Assisted Diagnostic System

    Time frame: Up to 60 minutes per case (upon completion of each case reading).

    Physician-reported usability of the AI system, assessed after completion of each AI-assisted case reading using a 10-point physician-rated usability scale. Scores range from 1 to 10, with higher scores indicating better system usability.

  4. Physician Reported Workload

    Time frame: Up to 60 minutes per case (upon completion of each case reading).

    Task-related workload experienced by physicians, assessed after completion of each AI-assisted case reading using a 10-point Physician Workload Likert scale. Scores range from 1 to 10, with higher scores indicating a higher workload.

  5. Physician Satisfaction

    Time frame: Up to 60 minutes per case (upon completion of each case reading).

    Overall satisfaction of physicians with the diagnostic workflow, assessed after completion of each AI-assisted case reading using a 10-point Satisfaction Likert scale. Scores range from 1 to 10, with higher scores indicating higher satisfaction.

  6. Physician Intention to Adopt AI-Assisted Diagnostic Support

    Time frame: Up to 60 minutes per case (upon completion of each case reading).

    Physician willingness to integrate AI system into routine clinical practice, assessed after completion of each AI-assisted case reading using a 10-point Adoption Intention Likert scale. Scores range from 1 to 10, with higher scores indicating higher adoption intention.

Study contacts

Contact information is provided by the study sponsor or research team.

Shuyang Zhang

CONTACT

[email protected]

+86-13911667211

Sponsors and collaborators

Lead sponsor

Peking Union Medical College Hospital

Other

Collaborators

  • Cangzhou Central Hospital
  • Dongguan People's Hospital
  • First People's Hospital of Foshan
  • Guizhou Provincial People's Hospital
  • Qinghai People's Hospital
  • The First People's Hospital of Yunnan
  • Tianjin Children's Hospital
  • Tibet Autonomous Region People's Hospital
  • Zhangzhou Municipal Hospital of Fujian Province

Registry information

Official study title

A Multicentre, Randomised Diagnostic Accuracy Study Evaluating AI Assisted Diagnosis of Rare Diseases

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jun 4, 2026
Registry last updated
Jun 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.